Compare ALEMBIC PHARMA with JUBILANT LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs JUBILANT LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA JUBILANT LIFE SCIENCES ALEMBIC PHARMA/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 16.3 14.1 115.9% View Chart
P/BV x 3.8 1.6 228.4% View Chart
Dividend Yield % 1.0 0.9 112.0%  

Financials

 ALEMBIC PHARMA   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
JUBILANT LIFE SCIENCES
Mar-19
ALEMBIC PHARMA/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs664898 73.9%   
Low Rs412618 66.8%   
Sales per share (Unadj.) Rs208.7572.0 36.5%  
Earnings per share (Unadj.) Rs31.036.2 85.6%  
Cash flow per share (Unadj.) Rs37.159.5 62.4%  
Dividends per share (Unadj.) Rs5.504.50 122.2%  
Dividend yield (eoy) %1.00.6 172.1%  
Book value per share (Unadj.) Rs144.2301.9 47.8%  
Shares outstanding (eoy) m188.52159.28 118.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.61.3 194.7%   
Avg P/E ratio x17.420.9 83.0%  
P/CF ratio (eoy) x14.512.7 113.9%  
Price / Book Value ratio x3.72.5 148.7%  
Dividend payout %17.712.4 142.8%   
Avg Mkt Cap Rs m101,461120,694 84.1%   
No. of employees `000NA2.4 0.0%   
Total wages/salary Rs m7,46719,260 38.8%   
Avg. sales/employee Rs ThNM38,120.6-  
Avg. wages/employee Rs ThNM8,058.4-  
Avg. net profit/employee Rs ThNM2,414.3-  
INCOME DATA
Net Sales Rs m39,34791,108 43.2%  
Other income Rs m94357 26.2%   
Total revenues Rs m39,44191,466 43.1%   
Gross profit Rs m8,73617,390 50.2%  
Depreciation Rs m1,1523,709 31.1%   
Interest Rs m1842,198 8.4%   
Profit before tax Rs m7,49311,840 63.3%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m0-2,802 0.0%   
Tax Rs m1,5683,268 48.0%   
Profit after tax Rs m5,8445,770 101.3%  
Gross profit margin %22.219.1 116.3%  
Effective tax rate %20.927.6 75.8%   
Net profit margin %14.96.3 234.5%  
BALANCE SHEET DATA
Current assets Rs m19,57745,848 42.7%   
Current liabilities Rs m14,89620,897 71.3%   
Net working cap to sales %11.927.4 43.4%  
Current ratio x1.32.2 59.9%  
Inventory Days Days9057 158.0%  
Debtors Days Days4551 89.0%  
Net fixed assets Rs m27,09765,498 41.4%   
Share capital Rs m377159 236.7%   
"Free" reserves Rs m26,81147,930 55.9%   
Net worth Rs m27,18848,089 56.5%   
Long term debt Rs m4,99342,429 11.8%   
Total assets Rs m47,778114,685 41.7%  
Interest coverage x41.76.4 653.0%   
Debt to equity ratio x0.20.9 20.8%  
Sales to assets ratio x0.80.8 103.7%   
Return on assets %12.66.9 181.6%  
Return on equity %21.512.0 179.1%  
Return on capital %23.612.4 190.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,45312,422 156.6%   
Fx outflow Rs m6,06517,227 35.2%   
Net fx Rs m13,388-4,805 -278.6%   
CASH FLOW
From Operations Rs m8,12011,215 72.4%  
From Investments Rs m-7,556-10,118 74.7%  
From Financial Activity Rs m5906,574 9.0%  
Net Cashflow Rs m1,1537,612 15.2%  

Share Holding

Indian Promoters % 74.1 45.6 162.5%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 2.9 8.7 33.3%  
FIIs % 9.1 21.2 42.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 21.1 65.9%  
Shareholders   49,328 23,815 207.1%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   TORRENT PHARMA  DR. DATSONS LABS  ELDER PHARMA  SANOFI INDIA  PANACEA BIOTECH  

Compare ALEMBIC PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Climbs 200 Points; Yes Bank and Reliance Industries Top Gainers(12:30 pm)

Share markets in India are presently trading on a positive note. All sectoral indices are trading in green with stocks in the capital goods sector.

Related Views on News

WOCKHARDT Surges by 5%; BSE HEALTHCARE Index Up 1.2% (Market Updates)

Oct 18, 2019 | Updated on Oct 18, 2019

WOCKHARDT share price has surged by 5% and its current market price is Rs 273. The BSE HEALTHCARE is up by 1.2%. The top gainers in the BSE HEALTHCARE Index are WOCKHARDT (up 5.3%) and JUBILANT LIFE SCIENCES (up 5.2%). The top losers are GSK PHARMA (down 0.1%) and PROCTER & GAMBLE HEALTH (down 0.2%).

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Oct 18, 2019 02:23 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - AUROBINDO PHARMA COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS